Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Sarcoma and MDM2[original query] |
|---|
| MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Sep 24 (27): 4434-40. Ohmiya Naoki, Taguchi Ayumu, Mabuchi Nobuyuki, Itoh Akihiro, Hirooka Yoshiki, Niwa Yasumasa, Goto Hide |
| Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. Journal of the National Cancer Institute 2006 Feb 98 (4): 285-8. Menin Chiara, Scaini Maria Chiara, De Salvo Gian Luca, Biscuola Martina, Quaggio Monica, Esposito Giovanni, Belluco Claudio, Montagna Marco, Agata Simona, D'Andrea Emma, Nitti Donato, Amadori Alberto, Bertorelle Rober |
| Recent natural selection identifies a genetic variant in a regulatory subunit of protein phosphatase 2A that associates with altered cancer risk and survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 15 (19): 6301-8. Grochola Lukasz F, Vazquez Alexei, Bond Elisabeth E, Würl Peter, Taubert Helge, Müller Thomas H, Levine Arnold J, Bond Gareth |
| MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2011 Feb 16 (1): 42-50. Tornesello Maria Lina, Buonaguro Luigi, Cristillo Medea, Biryahwaho Bennon, Downing Robert, Hatzakis Angelo, Alessi Elvio, Cusini Marco, Ruocco Vincenzo, Viviano Enza, Romano Nino, Katongole-Mbidde Edward, Buonaguro Franco |
| The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis. Journal of cancer research and clinical oncology 2012 Apr 138 (4): 555-61. Cai Xu, Yang Mi |
| Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma. Cancer 2013 Mar 119 (5): 1013-22. Ohnstad Hege O, Castro Russell, Sun Jinchang, Heintz Karen-Marie, Vassilev Lyubomir T, Bjerkehagen Bodil, Kresse Stine H, Meza-Zepeda Leonardo A, Myklebost O |
| Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study. The American journal of surgical pathology 2013 Aug 37 (8): 1259-68. Neuville Agnes, Ranchère-Vince Dominique, Dei Tos Angelo Paolo, Montesco Maria Cristina, Hostein Isabelle, Toffolatti Luisa, Chibon Frédéric, Pissaloux Daniel, Alberti Laurent, Decouvelaere Anne-Valérie, Albert Sabrina, Rossi Carlo Riccardo, Blay Jean-Yves, Coindre Jean-Mich |
| Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs. Molecular biology reports 2013 Aug 40 (8): 4929-34. Thurow Helena S, Hartwig Fernando P, Alho Clarice S, Silva Deborah S B S, Roesler Rafael, Abujamra Ana Lucia, de Farias Caroline Brunetto, Brunetto Algemir Lunardi, Horta Bernardo L, Dellagostin Odir A, Collares Tiago, Seixas Fabiana |
| Impact of MDM2 gene polymorphism on sarcoma risk. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Mar 36 (3): 1791-5. Zhang Dawei, Ding Yuanyuan, Wang Zhenlin, Wang Yan, Zhao Guangy |
| MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients. Medical microbiology and immunology 2017 Jan . Varmazyar Sajad, Marashi Sayed Mahdi, Shoja Zabihollah, Tornesello Maria Lina, Buonaguro Franco M, Shahmahmoodi Shohreh, Safaie-Naraghi Zahra, Jalilvand Somay |
| Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations. Oncotarget 2018 Apr 9 (28): 19891-19899. Somaiah Neeta, Beird Hannah C, Barbo Andrea, Song Juhee, Mills Shaw Kenna R, Wang Wei-Lien, Eterovic Karina, Chen Ken, Lazar Alexander, Conley Anthony P, Ravi Vinod, Hwu Patrick, Futreal Andrew, Simon George, Meric-Bernstam Funda, Hong Dav |
| Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Neuro-oncology 2019 2 21 (8): 981-992. Pemov Alexander, Hansen Nancy F, Sindiri Sivasish, Patidar Rajesh, Higham Christine S, Dombi Eva, Miettinen Markku M, Fetsch Patricia, Brems Hilde, Chandrasekharappa Settara C, Jones Kristine, Zhu Bin, Wei Jun S, , , Mullikin James C, Wallace Margaret R, Khan Javed, Legius Eric, Widemann Brigitte C, Stewart Douglas |
| TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma. British journal of cancer 2021 5 125 (4): 576-581. Casey Dana L, Pitter Kenneth L, Wexler Leonard H, Slotkin Emily K, Gupta Gaorav P, Wolden Suzanne |
| Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients. Cancer medicine 2022 May . Gan Meifu, Zhang Chen, Qiu Liqing, Wang Yue, Bao Hua, Yu Ruoying, Liu Rui, Wu Xue, Shao Yang, Hou Peifeng, Fei Zhengl |
| The landscape of alterations from 1407 ultra-rare sarcomas from the AACR GENIE database: Clinical implications. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 8 . Ryan A Denu, Justin T Moyers, Mohamed A Gouda, Anthony Conley, Alexander J Lazar, Vivek Subbi |
- Page last reviewed:Feb 1, 2024
- Content source: